I think the authorization serves two purposes: 1) to allow the spin off to occur, in which the authorized shares would fill the needed capitalization of the spinoff company and 2) attract institutions and hedge funds for investment purposes. Remember that spin offs are used mainly for the purpose of attracting big pockets when it comes to investments. If they do spin off, the new company would automatically be on the radar on major institution houses, which would stop the worrying about dilution. I have been thinking about what part of the company would actually serve us better in that scenario, and i have come to the conclusion that MANF would be the best because that part of the business is a couple years at least away from actually being commercialized. Because Lympro is right at the door step of commercialization, the revenues that stem from that exposure would best serve the stock in the short term. But, I also realize the big big bucks and value is in the MANF set of products, it is a coin toss. Granted I am still trying to catch up, I makes sense to keep guaranteed revenue generating assets with AMBS, and spin off the future generating aspect of the business so institutions can finance the growth on the open market with the purpose of buying a equity position. Works for all around, and quells the worries of further dilution and shareholder value. Any thoughts?
I think the authorization serves two purposes: 1) to allow
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Scinai Immunotherapeutics Reports Impressive Q1 Revenue Surge
Scinai Immunotherapeutics Reports Financial Achievements Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company specializing in innovative treatments for inflammation and immunology (I&I) diseases, recently shared its remarkable financial results for Q1 2025. This report highlights significant progress in its Contract Development and Manufacturing...
Continue Reading
CleanSpark Expands Growth Strategy with Doubling of Shares
CleanSpark Inc. Doubles Authorized Shares for Enhanced Flexibility CleanSpark, Inc. (NASDAQ: CLSK), a Nevada-based financial services company, has recently taken a significant step towards enhancing its growth potential by amending its Articles of Incorporation. The company announced an increase of its authorized common stock from 300 million to 600 million shares, a...
Continue Reading
Experience Exceptional Sound with New JLab Go Lux ANC Headphones
Introducing the JLab Go Lux ANC Wireless On-Ear Headphones JLab, a prestigious name in personal audio technology, has just announced an impressive addition to its Lux line with the Go Lux ANC On-Ear Headphones. Priced at an accessible $49.99, these headphones aim to set a new standard in wireless audio excellence, making them a must-have for anyone passionate about sound...
Continue Reading
Velan Inc. Announces Impressive Year-End Financial Results
Significant Full-Year Improvements by Velan Inc. Strong Year-End Performance with Increased Revenue and Profitability Velan Inc. (TSX: VLN), a prominent name in the industrial valve manufacturing sector, concluded its fiscal year with noteworthy progress. This was underscored by a remarkable 14.1% rise in sales from continuing operations, which reached around $295.2...
Continue Reading
Experience the Innovation of PXG's Lightning Metalwoods Series
Introduction to PXG Lightning Metalwoods PXG has launched the Lightning Metalwoods series, a product line that redefines the standards of golf equipment. Featuring innovative engineering, this latest technology focuses on delivering an unparalleled experience. From improved speed and distance to precision in ball control, PXG's latest offerings cater to players at all...
Continue Reading